A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors
Clinical trial NCT05839639 · COMPLETED
Trial details
- NCT number
- NCT05839639
- Sponsor
- Huahui Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-09
- Primary completion
- 2022-12-05
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.